Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Prif Awdur: | Moreino, Shannon Sherwin |
---|---|
Awduron Eraill: | Kabir, Eva Rahman |
Fformat: | Project report |
Iaith: | English |
Cyhoeddwyd: |
BRAC University
2018
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/9331 |
Eitemau Tebyg
-
Biologics and Biosimilars as Treatment Options for Psoriasis
gan: Moya, Amena Khatun
Cyhoeddwyd: (2023) -
Biosimilar in lymphoma treatment
gan: Tanisha, Mehrin Haque
Cyhoeddwyd: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
gan: Tabassum, Turana
Cyhoeddwyd: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
gan: Tania, Umme
Cyhoeddwyd: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
gan: Tania, Umme
Cyhoeddwyd: (2023)